Across
- 1. Ad-Hoc Committee
- 2. Artemisinin-based Combination Therapy
- 5. Country Coordinating Mechanism
- 7. Malaria Indicator Survey
- 9. Antenatal Clinic
- 11. Sulfadoxine Pyrimethamine
- 12. Rapid Diagnostic Test
- 13. Green Light Committee
- 16. Community Health Worker
- 18. Most at-risk population
- 19. Technical Assistance
- 21. Finance and Operational Performance Committee
- 23. United Nations General Assembly Special Session
- 24. New Funding Model
- 26. Demographic Health Survey
- 28. Roll Back Malaria
- 31. Continuation of Service
- 33. Prevention of Mother to Child Transmission
- 34. Ministry of Health
- 35. Grant Approval Committee
- 36. Swiss Centre for International Health
- 37. Acquired immune deficiency syndrome
- 40. Technical Review Panel
- 41. Sub-Recipient
- 42. Government Health Expenditure
- 43. Market Dynamics Advisory Group
- 44. Gross Domestic Product
- 45. Injecting Drug User
- 47. Progress Update / Disbursement Request
Down
- 1. Audit and Ethic Committee
- 2. Affordable Medicines Facility-malaria
- 3. Data Quality Audit
- 4. Behaviour Change Communications
- 6. Multidrug Resistant
- 8. Information Education Communication
- 10. National Malaria Control Program
- 11. Sexually transmitted infection
- 14. Long-lasting insecticide treated net
- 15. Health management information system
- 17. World Health Organization
- 19. Transitional Funding Mechanism
- 20. Highly active antiretroviral therapy
- 22. Pan American Health Organization
- 25. Faith-based Organization
- 27. Co-payment Advisory Group
- 29. Medicines for Malaria Venture
- 30. Community Home Based Care
- 32. Strategy, Investment and Impact Committee
- 33. Person living with HIV/AIDS
- 36. Service Delivery Point
- 38. United Kingdom Department for International Development
- 39. Principal Recipient
- 40. Technical Evaluation Reference Group
- 41. Sexual Orientation and Gender Identities
- 43. Millennium Development Goals
- 46. US Dollar